ACGX yields 5464.48% · ABBV yields 3.06%● Live data
📍 ACGX pulled ahead of the other in Year 1
Combined, ACGX + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ACGX + ABBV for your $10,000?
Alliance Creative Group, Inc. operates as a creative packaging and digital engagement company in the United States. The company provides creative and design services, including advertising campaigns, art direction, brand identity, graphic design, strategy and planning, logo design, Website design, collateral design, video production, conversion copywriting, blog and keyword planning, package design, and photography; and club packs, corrugate, flexible, folding carton, pallet display, pre-print, custom, stock, and thermo-forming packaging services. It also offers supply chain management services, such as third-party logistics, trucking and distribution, vendor managed inventory, and warehousing; commercial, digital, direct mail, grand format, large format, offset, catalog, design support, outdoor signage, and Web printing services; and brand audit and research, brand strategy, communication planning, content planning, event planning, event advisory, and PR advisory services. In addition, the company provides content creation, online marketing, customer engagement, business consulting and strategic marketing, software development, digital engagement, and logistics/VMI services. It offers its services under the St. Louis Packaging, STL Graphics, Snap Graphics, Print4aCause, CoporateGifts4aCause, and PeopleVine brand names to automotive, beauty and wellness, confectionery, food and beverage, gaming and electronics, home enhancement, music and entertainment, pet care, restaurant, sports, technology, and wine and spirits industries. The company was formerly known as Invicta Group, Inc. and changed its name to Alliance Creative Group, Inc. in November 2010. Alliance Creative Group, Inc. was founded in 2000 and is headquartered in East Dundee, Illinois.
Full ACGX Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.